Position in CAMP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,661,957
-$8,947,650 QoQ
Shares Held
2,190,920
-27.8% QoQ
Ownership
4.22%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
#6
of 46 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CAMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENAVATE SCIENCES GP, LLC holds $351,507,327 across 7 Biotechnology names. CAMP ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SION |
Sionna Therapeutics, Inc.
|
2,478,030 | $99,344,222 | |
| 2 | IMNM |
Immunome Inc.
|
3,613,799 | $79,033,784 | |
| 3 | ZBIO |
Zenas BioPharma, Inc.
|
3,919,159 | $76,619,558 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
7,788,150 | $41,199,313 | |
| 5 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,626,946 | $23,511,166 | |
| 6 | UPB |
Upstream Bio, Inc.
|
2,459,703 | $22,137,327 | |
| 7 | CAMP |
Camp4 Therapeutics Corp
This page
|
2,190,920 | $9,661,957 |
All Filings in CAMP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,661,957 | 2,190,920 | Shares | Sole | 2026-05-15 | |
| 2026-03-09 | $15,659,651 | 2,495,562 | Shares | Sole | 2026-03-11 | |
| 2025-12-31 | $18,609,607 | 3,035,825 | Shares | Sole | 2026-02-17 | |
| 2025-12-19 | $19,952,556 | 3,127,360 | Shares | Sole | 2025-12-23 | |
| 2025-09-30 | $11,357,406 | 3,785,802 | Shares | Sole | 2025-11-14 | |
| 2025-09-11 | $10,524,529 | 3,785,802 | Shares | Sole | 2025-09-15 | |
| 2025-06-30 | $5,489,412 | 3,785,802 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,143,208 | 3,785,802 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $19,761,886 | 3,785,802 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||